CHIR-258 Is Efficacious in A Newly Developed Fibroblast Growth Factor Receptor 3–Expressing Orthotopic Multiple Myeloma Model in Mice von XIAOHUA XIN, ABRAMS, Tinya J, TRUDEL, Suzanne, JALLAL, Bahija, MENDEL, Dirk B, HEISE, Carla C, HOLLENBACH, Paul W, RENDAHL, Katherine G, YAN TANG, OEI, Yoko A, EMBRY, Millicent G, SWINARSKI, Debbie E, GARRETT, Evelyn N, PRYER, Nancy K

Volltext

Neutralization of prolactin receptor function by monoclonal antibody LFA102, a novel potential therapeutic for the treatment of breast cancer von Damiano, Jason S, Rendahl, Katherine G, Karim, Christopher, Embry, Millicent G, Ghoddusi, Majid, Holash, Jocelyn, Fanidi, Abdallah, Abrams, Tinya J, Abraham, Judith A

Volltext

CHIR-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons In vitro and In vivo von TSE, Archie N, RENDAHL, Katherine G, HIBNER, Barbara, GESNER, Thomas G, SCHWARTZ, Gary K, SHEIKH, Tahir, CHEEMA, Haider, AARDALEN, Kim, EMBRY, Millicent, MA, Sylvia, MOLER, Edward J, ZHI JIE NI, LOPES DE MENEZES, Daniel E

Volltext